new amsterdam - ( business news ) sanofi inc announced today that it has formed the first pharmaceutical company to be designated by the association for the improvement of patient experiment protection programs ( aahrpp ) for securing the protection of human agents in part in early - stage clinical trials . the aahrpp authorization was awarded to pfizer ' s clinical investigation units ( crus ) in fort haven , ct , brussels , belgian and singapore , where the company performed most of its phase i clinical practice . to earn the accreditation , pfizer participated in a intensive , 15 - months examination of the clinical development practices at these units .
Pfizer is a pharmaceutical company.